Evidence map›Paper›PMID 42483293›Full record

ArticleMaternal-fetal medicine (Wolters Kluwer Health, Inc.)2026

Clinical Characteristics of Early-Onset Severe Hemolytic Disease of the Fetus and Newborn and Treatment Efficacy of Serial Intrauterine Transfusions: A 10-Year Single-Center Experience in China.

Quanrui Liu, Jingya Zhao, Jingyu Liu, Danlun Li, Zhiming He, Yanmin Luo, Yi Zhou

Abstract read
In one paragraph

Article in Maternal-fetal medicine (Wolters Kluwer Health, Inc.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Quanrui LiuDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Jingya ZhaoDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Jingyu LiuDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Danlun LiDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Zhiming HeDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Yanmin LuoDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
Yi ZhouDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To summarize the clinical characteristics of early-onset severe hemolytic disease of the fetus and newborn (HDFN) in a Chinese cohort and identify factors influencing intrauterine transfusion (IUT) frequency and pregnancy outcomes. Methods: This retrospective cohort study included cases managed between 2013 and 2022. Factors affecting IUT efficacy were analyzed with regard to subsequent IUT risk and adverse pregnancy outcomes. Survival analysis for recurrent events was performed to assess subsequent IUT risk. Results: Of the 97 cases included, 38 were identified as early-onset severe HDFN. Compared with non-early-onset severe HDFN, early-onset severe HDFN was characterized by higher anti-D titer (1:1024 Conclusion: The characteristics of early-onset severe HDFN in Chinese patients are different from those observed in western cohorts. These patients frequently present with higher anti-D titers and a more complex spectrum of multiple alloantibodies. The occurrence of early-onset severe HDFN is associated with an increased frequency of IUT and lower live birth rates. Therefore, exploring effective interventions to delay the first IUT is critical to optimizing the timing and efficacy of intrauterine management for these high-risk cases.

Indexed as

Blood transfusion, intrauterineChineseHemolytic disease of the fetus and newbornSurvival analysis

Identifiers

PMID42483293
PMCPMC13387801

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.